A study co-led by a professor at Albert Einstein College of Medicine uncovered human antibodies that can defend against all forms of ebolavirus. By analyzing the blood of a person who survived the 2013-16 Ebola outbreak, a group of researchers were able to pinpoint antibodies that could neutralize and protect animals from all three major disease-causing ebolaviruses. Current antibody therapies for the virus family target only a single specific ebolavirus, but the findings in this study are a major step toward the goal of developing a single antibody therapy that would successfully defend against all known ebolaviruses.
The team of scientists used NYSERNet’s R&E network to exchange data and collaborate on their research.
Read more at http://www.einstein.yu.edu/news/releases/1241/researchers-discover-first-human-antibodies-that-work-against-all-ebolaviruses/.